Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Biorxiv : the Preprint Server for Biology
|
April 25, 2024
Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells
Tomasz Grzywa, Naveen Mehta, Benjamin Cossette, et al.
Journal of Clinical Medicine
|
April 3, 2021
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target
Zhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Nature Biomedical Engineering
|
August 25, 2025
Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells
Tomasz M Grzywa, Alexandra Neeser, Ranjani Ramasubramanian, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies
Quoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere, et al.
Nature
|
April 29, 2026
Spatial atlas of diabetic kidney disease reveals a B cell-rich subgroup
Bernhard Dumoulin, Jonathan Levinsohn, Konstantin A Klötzer, et al.
Cancer Cell
|
February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Patrizia Porazzi, Siena Nason, Ziqi Yang, et al.
NEJM Evidence
|
May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with Lymphoma
Guido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.
Blood Advances
|
December 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines
Guido Ghilardi, Luca Paruzzo, Jakub Svoboda, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Biorxiv : the Preprint Server for Biology
|
April 25, 2024
Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells
Tomasz Grzywa, Naveen Mehta, Benjamin Cossette, et al.
Journal of Clinical Medicine
|
April 3, 2021
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target
Zhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Nature Biomedical Engineering
|
August 25, 2025
Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells
Tomasz M Grzywa, Alexandra Neeser, Ranjani Ramasubramanian, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies
Quoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere, et al.
Nature
|
April 29, 2026
Spatial atlas of diabetic kidney disease reveals a B cell-rich subgroup
Bernhard Dumoulin, Jonathan Levinsohn, Konstantin A Klötzer, et al.
Cancer Cell
|
February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Patrizia Porazzi, Siena Nason, Ziqi Yang, et al.
NEJM Evidence
|
May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with Lymphoma
Guido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.
Blood Advances
|
December 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines
Guido Ghilardi, Luca Paruzzo, Jakub Svoboda, et al.
Page
of 5